Publications by authors named "Mohammad Dastbaz"

Claim this Profile
C
Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression.
Parviz Soufivand, Ghazal Hosseini Torshizi, Seyed Askar Roghani, Mohammad Dastbaz, Ramin Lotfi

Inflammopharmacology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19.
Seyed Askar Roghani, Mohammad Dastbaz, Ramin Lotfi, Afsaneh Shamsi, Zahra Abdan

Immun Inflamm Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the gene expression of the adenosine 5'-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients.
Shirin Assar, Mohammad Dastbaz, Komail Amini, Seyed Askar Roghani, Ramin Lotfi

Mol Biol Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis